Securing circulation pharmaceutically: Antiviral stockpiling and pandemic preparedness in the European Union

Security Dialogue

Volumn 45, Issue 5, 2014, Pages 440-457

  Elbe, Stefan ^a   Roemer Mahler, Anne ^a   Long, Christopher ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

antivirals; circulation; governmentality; pandemic preparedness; pharmaceuticalization; stockpile; Tamiflu

Indexed keywords

EID: 84910631655     PISSN: 09670106     EISSN: 14603640     Source Type: Journal    
DOI: 10.1177/0967010614530072     Document Type: Article

References (58)

1. Abraham J.Pharmaceuticalization of society in context: Theoretical, empirical and health dimensions.Sociology. 2010;44 (4): 603-622
2. Abraham J.Evolving sociological analyses of ‘pharmaceuticalisation’: A response to Williams.Sociology of Health & Illness. 2011;33 (5): 726-728
3. Anderson B.Preemption, precaution, preparedness: Anticipatory action and future geographies.Progress in Human Geography. 2010;34 (6): 777-798
4. Aradau C,Van Munster RPolitics of Catastrophe: Genealogies of the Unknown. Abingdon and New York: Routledge; 2011:
5. Brundtland GH.Global health and international security.Global Governance. 2003;9 (4): 417-423
6. Biomedicalization: Technoscience, Health and Illness in the U.S. Clarke AMamo LFosket J, ed. Durham, NC: Duke University Press; 2010:
7. Cohen D,Carter P.Conflicts of interest: WHO and the pandemic flu ‘conspiracies’.British Medical Journal. 2010;340:1274-1279
8. Continuity Central (2012) Roche introduces program to facilitate corporate pandemic stockpiling of Tamiflu. Available at: http://www.continuitycentral.com/news04019.htm (accessed 22 February 2013).
9. Cooper MLife as Surplus: Biotechnology and Capitalism in the Neoliberal Era. Seattle, WA: University of Washington Press; 2008:
10. Davies S.Securitizing infectious disease.International Affairs. 2008;84 (2): 295-313
11. De Goede M.Beyond risk: Premediation and the post-9/11 security imagination.Security Dialogue. 2008;39 (2): 155-176
12. Dillon M,Lobo-Guerrero L.Biopolitics of security in the 21st century: An introduction.Review of International Studies. 2008;34 (2): 265-292
13. Diprose R,Stephenson N,Mills C, et al.Governing the future: The paradigm of prudence in political technologies of risk management.Security Dialogue. 2008;39 (2–3): 267-288
14. Elbe SStrategic Implications of HIV/AIDS. Oxford and New York: Oxford University Press; 2003:
15. Elbe S.Should HIV/AIDS be securitized? The ethical dilemmas of linking HIV/AIDS and security.International Studies Quarterly. 2006;50 (1): 119-144
16. Elbe S.Our epidemiological footprint: The circulation of avian flu, SARS, and HIV/AIDS in the world economy.Review of International Political Economy. 2007;15 (1): 116-130
17. Elbe SVirus Alert: Security, Governmentality and the AIDS Pandemic. New York: Columbia University Press; 2009:
18. Elbe S.Haggling over viruses: The downside risks of securitizing infectious disease.Health Policy and Planning. 2010a;25 (6): 476-485
19. Elbe SSecurity and Global Health: Towards the Medicalization of Insecurity. Cambridge: Polity; 2010b:
20. Elbe S.Virus alert: Pandemics and the ‘darker’ side of globalization.ISPI: Quaderni di Relazioni Internazionali. 2012;16:78-89
21. Enemark C.Is pandemic flu a security threat?.Survival. 2009;51 (1): 191-214
22. European Commission (2009) Commission Staff Working Document on Health Security in the European Union and Internationally. 23November. Available at: http://ec.europa.eu/health/preparedness_response/docs/commission_staff_healthsecurity_en.pdf.
23. European Commission (2011) Stakeholder Consultation on Health Security in the European Union. 9September. Available at: http://ec.europa.eu/health/preparedness_response/consultations/preparedness_cons_02_en.htm.
24. European Council (2008) Council Conclusions on Health Security. 16December. Available at: http://www.consilium.europa.eu/ueDocs/cms_Data/docs/pressData/en/lsa/104770.pdf.
25. European Union (EU) (2013) Presidency confirms agreement on strengthening responses to serious cross-border health threats. Available at: http://www.eu2013.ie/news/news-items/20130516crossborderhealthupdateengonly/ (accessed 28 May 2013).
26. Foucault MThe History of Sexuality: An Introduction. London: Penguin; 1976:
27. Foucault MSpace, Knowledge and Power: Foucault and Geography. Crampton JElden S, ed. Aldershot: Ashgate; [1981] 2007:153-162.
28. Foucault MSecurity, Territory, Population: Lectures at the Collège de France 1977–1978. New York: Palgrave Macmillan; 2007:
29. Global Health Security Initiative (GHSI) (2002) Ministerial statement. London, March. Available at: http://ghsi.ca/english/statementlondonmar2002.asp (accessed 4April2014).
30. Jefferson T,Jones M,Doshi P, et al.Neuraminidase inhibitors for preventing and treating influenza in healthy adults.Cochrane Database of Systematic Reviews. 2010;2010 (2):
31. Lakoff APharmaceutical Reason: Knowledge and Value in Global Psychiatry. Cambridge: Cambridge University Press; 2005:
32. Lakoff A.The generic biothreat, or, how we became unprepared.Cultural Anthropology. 2008;23 (3): 399-423
33. Biosecurity Interventions: Global Health and Security in Question. Lakoff ACollier SJ, ed. New York: Columbia University Press; 2008:
34. McInnes C,Lee K.Health, security and foreign policy.Review of International Studies. 2006;32 (1): 5-23
35. McInnes C,Rushton S.HIV/AIDS and securitization theory.European Journal of International Relations. 2013;19 (1): 115-138
36. National Audit Office (NAO) (2013) Access to Clinical Trial Information and the Stockpiling of Tamiflu. 21May. London: Stationery office. Available at: http://www.nao.org.uk/wp-content/uploads/2013/05/10155-001_Access-to-clinical-trial-info-and-the-stockpiling-ofTamiflu_21-May.pdf.
37. Managing Materials for a Twenty-first Century Military. Washington, DC: The National Academies Press; 2008:
38. Nicoll A,Sprenger M.Learning lessons from the 2009 pandemic: Putting infections in their proper place.European Journal of Epidemiology. 2011;26 (3): 191-194
39. Petryna A,Lakoff A,Kleinman AGlobal Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke University Press; 2007:
40. Reddy D.Responding to pandemic (H1N1) 2009 influenza: The role of oseltamivir.Journal of Antimicrobial Chemotherapy. 2010;65:35-40
41. Routledge Handbook of Global Health Security. Rushton SYoude J, ed. Oxford: Routledge; 2014:
42. SamiiRVan WassenhoveL (2008) Fighting the Flu: Tamiflu Stockpiling: A Pandemic Preparedness Policy. Insead. Available at: www.insead.edu/facultyresearch/centres/isic/021HRG.pdf.pdf (accessed 2 April 2014).
43. Samimian-Darash L.Governing through time: Preparing for future threats to health and security.Sociology of Health and Illness. 2011;33 (6): 930-945
44. Samimian-Darash L.Governing future potential biothreats: Toward an anthropology of uncertainty.Current Anthropology. 2013;54 (1): 1-22
45. SchneiderR (2001) Das Rennen um GS4104: Wie ein Medikament entwickelt, getestet und vermarktet wird [The race to develop GS4104]. NZZ Folio: Die Zeitschrift der Neuen Zuercher Zeitung. April. Available at: http://www.nzzfolio.ch/www/d80bd71b-b264-4db4-afd0-277884b93470/showarticle/81bb3c96-9216-4eb5-b602-7e0937369c79.aspx (accessed 1 March 2012).
46. Smith RD,Keogh-Brown MR,Barnett T, et al.The economy-wide impact of pandemic influenza on the UK: A computable general equilibrium modelling experiment.British Medical Journal. 2009;339:
47. Snyder GStockpiling Strategic Materials: Politics and National Defense. San Francisco, CA: Chandler; 1966:
48. StantonJ (2005) Big stakes in Tamiflu debate. RollCall, 15December. Available at: http://www.rollcall.com/issues/51_64/news/11597-1.html (accessed 1 July 2010).
49. Stephenson N,Jamieson M.Securitizing health: Australian newspaper coverage of pandemic influenza.Sociology of Health & Illness. 2009;31 (4): 525-539
50. Trakatellis A.Pandemic Influenza in the EU: Are We Sufficiently Prepared?. 2007;:
51. TurnerS (2005) Roche sales up 20% as Tamiflu sought. MarketWatch: The Wall Street Journal, 19October. Available at: http://www.marketwatch.com/story/roche-sales-rise-20-on-cancer-tamiflu-drugs.
52. WhitehallG (2010) Preemptive sovereignty and avian pandemics. Theory & Event13(2). Available at: https://muse.jhu.edu/journals/theory_and_event/v013/13.2.whitehall.html (accessed 4 April 2014).
53. Whyte SR,Van der Geest S,Hardon ASocial Lives of Medicines. Cambridge: Cambridge University Press; 2002:
54. Pharmaceuticals and Society: Critical Discourses and Debates. Williams SGabe JDavis P, ed. Oxford: Wiley-Blackwell; 2009:
55. Williams SJ,Martin PA,Gabe J.The pharmaceuticalisation of society? An analytical framework.Sociology of Health & Illness. 2011;33 (5): 710-725
56. Global Health Security – Epidemic Alert and Response. Geneva: WHA; 2001:
57. A Safer Future: Global Public Health Security in the 21st Century. Geneva: WHO; 2007 2007:
58. World Health Organization (WHO) (2009) Safety of pandemic vaccines. Geneva: WHO. Available at: http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/index.html (accessed 4 April 2014).